// App-Quantinova.ai

: Real World Experience: Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia in Mexico

Researchers

Presenter

  • Silvia Berenice Sanchez Campos

Principal Investigators

  • Victor Itaí Urbalejo Ceniceros

  • Dana Aline Perez Camargo

Medical Centers

  • Hematology Department, Instituto Nacional de Cancerología, México, Mexico

  • Hematology, Instituto Nacional de Cancerología, Ciudad De Mexico, MEX

  • Nutrition Department, Instituto Nacional de Cancerología, Mexico City, Mexico

Locations

  • Mexico

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Blinatumomab

Outcome

  • N/A

Study Design

  • Observational

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved